Home > Insider Trading > Filing (0001209191-18-014617)

Filing Details

Accession Number:: 0001209191-18-014617
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-02-28 17:51:37
Reporting Period:: 2018-02-26

Accepted Time:: 2018-02-28 17:51:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1294133	Inogen Inc	INGN	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1616363	D. Heather Rider	C/O Inogen, Inc. 326 Bollay Drive Goleta CA 93117		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-02-26	2,222	$18.93	3,222	No	4	M	Direct
Common Stock	Acquisiton	2018-02-26	3,000	$43.21	6,222	No	4	M	Direct
Common Stock	Disposition	2018-02-26	3,303	$130.71	2,919	No	4	S	Direct
Common Stock	Disposition	2018-02-26	1,277	$131.49	1,642	No	4	S	Direct
Common Stock	Disposition	2018-02-26	642	$132.61	1,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2018-02-26	2,222	$0.00	2,222	$18.93
Common Stock	Stock Option (right to buy)	Disposition	2018-02-26	3,000	$0.00	3,000	$43.21

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-08-15	No	4	M	Direct
7,000		2022-10-13	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,000	Indirect	By spouse

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2017.
Represents the weighted average share price of an aggregate total of 3,303 shares sold in the price range of $130.21 to $131.17 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average share price of an aggregate total of 1,277 shares sold in the price range of $131.22 to $131.99 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average share price of an aggregate total of 642 shares sold in the price range of $132.17 to $132.95 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is August 15, 2014.
Previously filed form 4 reported an incorrect expiration date.
Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option shall vest monthly, beginning with the first month anniversary after the vesting commencement date, but will vest fully on the date of the next Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option is October 14, 2015.